Title |
Goals of statin therapy: Three viewpoints
|
---|---|
Published in |
Current Atherosclerosis Reports, January 2002
|
DOI | 10.1007/s11883-002-0059-6 |
Pubmed ID | |
Authors |
Gilbert R. Thompson, Christopher J. Packard, Neil J. Stone |
Abstract |
The "lipid hypothesis" is now universally recognized as a law. Few issues in medicine are as completely resolved as the question of whether reducing serum cholesterol increases longevity. However, there are a few questions that remain, and the most important uncertainty is to what extent cholesterol should be reduced. The medical community, in partnership with government and industry, has contributed many excellent trials demonstrating the effects in patients with elevated cholesterol (above the mean). Where should our goal of therapy be? Until data is available from several large, ongoing trials, we do not have a final answer. We asked three investigators, Drs. Gilbert Thompson, Christopher Packard, and Neil Stone, who have all been integrally involved in the accumulation of our present database, to argue three different possible answers. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 14% |
Unknown | 6 | 86% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 2 | 29% |
Librarian | 1 | 14% |
Student > Bachelor | 1 | 14% |
Other | 1 | 14% |
Student > Ph. D. Student | 1 | 14% |
Other | 1 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 57% |
Psychology | 1 | 14% |
Agricultural and Biological Sciences | 1 | 14% |
Unknown | 1 | 14% |